Inventor · disambiguated record
Al Y. Lin
Also filed as: LIN AL Y
7 granted patents·16 pending applications·103 citations·filing 2002–2022
86Inventor score
Top patents by PatentIndex Score
23 records- 0193US10927081B2Enhanced erythropoiesis and iron metabolismFIBROGEN INC·Filed 2018·Granted Feb 23, 2021·3 cites·46 claims
- 0293US7405274B2Connective tissue growth factor antibodiesFIBROGEN INC·Filed 2004·Granted Jul 29, 2008·47 cites·28 claims
- 0392US7871617B2Antibodies that bind to a portion of the VWC domain of connective tissue growth factorFIBROGEN INC·Filed 2008·Granted Jan 18, 2011·16 cites·45 claims
- 0489US11680047B2Enhanced erythropoiesis and iron metabolismFIBROGEN INC·Filed 2020·Granted Jun 20, 2023·1 cites·23 claims
- 0589US7618940B2Fat regulationFIBROGEN INC·Filed 2003·Granted Nov 17, 2009·35 cites·16 claims
- 0684US2024076364A1Connective tissue growth factor antibodiesFIBROGEN INC·Filed 2022·Application pending·0 cites
- 0779US2021369702A1Methods for treating anemia in subjects having kidney failure using inhibitors of hypoxia-inducible factor (hif) hydroxylaseFIBROGEN INC·Filed 2021·Application pending·0 cites
- 0875US9034643B2Connective tissue growth factor antibodiesFIBROGEN INC·Filed 2012·Granted May 19, 2015·1 cites·12 claims
- 0974US2021230259A1Connective tissue growth factor antibodiesFIBROGEN INC·Filed 2020·Application pending·0 cites
- 1067US2019023778A1Connective tissue growth factor antibodiesFIBROGEN INC·Filed 2018·Application pending·0 cites
- 1167US2015080425A1Methods for treating anemia in subjects having kidney failure using inhibitors of hypoxia-inducible factor (hif) hydroxylaseKLAUS STEPHEN J·Filed 2014·Application pending·0 cites
- 1265US2017312268A1Methods for treating a neurological disorder in a subject using inhibitors of hypoxia-inducible factor (hif) proyl hydroxylaseFIBROGEN INC·Filed 2017·Application pending·0 cites
- 1363US2013203805A1Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylaseKLAUS STEPHEN J·Filed 2012·Application pending·0 cites
- 1461US2006178317A1Methods of increasing endogenous erythropoietin (EPO)FIBROGEN INC·Filed 2006·Application pending·0 cites
- 1561US2006183695A1Methods of increasing endogenous erythropoietin (EPO)FIBROGEN INC·Filed 2006·Application pending·0 cites
- 1661US2006178316A1Methods of increasing endogenous erythropoietin (EPO)FIBROGEN INC·Filed 2006·Application pending·0 cites
- 1760US2011166178A1Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylaseFIBROGEN INC·Filed 2011·Application pending·0 cites
- 1860US2016257740A1Connective Tissue Growth Factor AntibodiesFIBROGEN INC·Filed 2016·Application pending·0 cites
- 1958US8202834B2Fat regulationFOURNEY PATRICK D·Filed 2009·Granted Jun 19, 2012·0 cites·27 claims
- 2057US2011091468A1Connective tissue growth factor antibodiesFIBROGEN INC·Filed 2010·Application pending·0 cites
- 2157US2016024198A1Connective tissue growth factor antibodiesFIBROGEN INC·Filed 2015·Application pending·0 cites
- 2255US2003153503A1Methods of increasing endogenous erythropoietin (EPO)Filed 2002·Application pending·0 cites
- 2344US2015018384A1Treatment for high cholesterolFIBROGEN INC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Al Y. Lin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →